Covered recipient · General Payments record
MIA JOANN HYDE
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$476.52
- Reported across 33 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $223.26 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $142.14 | 14 |
| GENZYME CORPORATION | $21.06 | 1 |
| Teva Pharmaceuticals USA, Inc. | $17.28 | 1 |
| Novo Nordisk AS | $14.94 | 1 |
| Lilly USA, LLC | $13.92 | 1 |
| SANOFI PASTEUR INC. | $13.92 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.24 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107378902 | CMS |
| ABBVIE INC. | $18.08 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107378904 | CMS |
| ABBVIE INC. | $19.87 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107378906 | CMS |
| ABBVIE INC. | $6.96 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107378908 | CMS |
| ABBVIE INC. | $1.71 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107378910 | CMS |
| ABBVIE INC. | $8.94 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107378912 | CMS |
| ABBVIE INC. | $5.28 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107378914 | CMS |
| ABBVIE INC. | $1.43 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107378916 | CMS |
| ABBVIE INC. | $7.86 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107378918 | CMS |
| ABBVIE INC. | $1.91 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107378920 | CMS |
| ABBVIE INC. | $18.52 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107378922 | CMS |
| ABBVIE INC. | $21.34 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107378924 | CMS |
| ABBVIE INC. | $6.00 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107378926 | CMS |
| ABBVIE INC. | $6.00 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107378928 | CMS |
| GENZYME CORPORATION | $21.06 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139713360 | CMS |
| Lilly USA, LLC | $13.92 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135821940 | CMS |
| Novo Nordisk Inc | $14.94 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100547634 | CMS |
| SANOFI PASTEUR INC. | $13.92 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128741854 | CMS |
| Teva Pharmaceuticals USA, Inc. | $17.28 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151551499 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.